L

LAVA Therapeutics NV
D

LVTX

1.32000
USD
-0.03
(-2.22%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
34,722,989
أصول ذات صلة
A
ANVS
0.03000
(1.14%)
2.67000 USD
A
AVXL
0.12000
(1.35%)
9.03000 USD
I
IMUX
-0.01750
(-2.28%)
0.75000 USD
I
INNV
0.07000
(1.87%)
3.81400 USD
M
MNOV
0.03000
(2.36%)
1.30000 USD
O
OMER
0.01000
(0.31%)
3.21500 USD
S
SAVA
-0.00500
(-0.24%)
2.06500 USD
المزيد
الأخبار المقالات

العنوان: LAVA Therapeutics NV

القطاع: Healthcare
الصناعة: Biotechnology
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.